Gossamer Bio Inc
GOSS
NASDAQ
Biotechnology
$0.15
USD
-0.02 (-9.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $81.25M
Volume 13.5M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
GOSS | Gossamer Bio Inc | $81.25M | - | -55.4% | - | |
CRDF | Cardiff Oncology Inc | $79.27M | - | -10.7% | - | |
SERA | Sera Prognostics Inc | $78.71M | - | -50.4% | - | |
ACET | Adicet Bio Inc | $77.89M | - | - | - | |
NMAD | NOMAD Power Solutions, Inc | $76.83M | - | - | - | |
ELTX | Elicio Therapeutics Inc | $73.92M | - | -91.9% | - | |
SPRO | Spero Therapeutics Inc | $72.09M | 4.73 | +37.2% | - | |
IBIO | iBio Inc | $69.55M | - | -20.0% | - | |
CYPH | Cypherpunk Technologies Inc | $68.49M | - | - | - |
Top Peer by Growth
Spero Therapeutics Inc
+37.2% YoY Revenue
Lowest P/E Ratio
Spero Therapeutics Inc
4.73x P/E
Best 1-Year Return
iBio Inc
+92.0% Return